A. Fabre (Dublin 4, Ireland), A. Mailleux (Paris, France)
Differential mast cell activation by transcriptomic signature analysis in the U-BIOPRED severe asthma cohort
A. TIOTIU (Nancy, France), Y. Badi (London, United Kingdom), N. Zounemat Kermani (London, United Kingdom), P. Hansbro (Newcastle, Australia), C. Wheelock (Stockholm, Sweden), S. Dahlen (Stockholm, Sweden), Y. Guo (London, United Kingdom), P. Sterk (Amsterdam, Netherlands), R. Djukanovic (Southampton, United Kingdom), I. Adcock (London, United Kingdom), F. Chung (London, United Kingdom)
|   |
Alteration of Plasma Exosome Content in Acute Respiratory Distress Syndrome: a miRNA signature associated to lung fibrosing process.
G. Parzibut (Liege, Belgium), J. Guiot (Liege, Belgium), B. Misset (Liege, Belgium), M. Malaise (Liege, Belgium), R. Louis (Liege, Belgium), E. Louis (Liege, Belgium), M. Henket (Liege, Belgium), C. Moermans (Liege, Belgium), S. Njock (Liege, Belgium)
| |
Profiling of airway epithelial proteome reveals sex differences in early stage COPD linked to xenobiotic metabolism and ER stress
T. Heyder (Stockholm, Sweden), M. Yang (Stockholm, Sweden), M. Kohler (Stockholm, Sweden), H. Merikallio (Stockholm, Sweden), H. Forsslund (Stockholm, Sweden), C. Li (Stockholm, Sweden), R. Karimi (Stockholm, Sweden), J. Grunewald (Stockholm, Sweden), R. Kaarteenaho (Oulu, Finland), C. Sihlbom (Gothenburg, Sweden), C. Skold (Stockholm, Sweden), Å. Wheelock (Stockholm, Sweden)
|   |
Impact of histaminergic H3 receptor antagonist on hypoglossal nucleus in chronic intermittent hypoxia conditions
L. Xie (Shanghai, China), S. Li (Shanghai, China)
| |
Differentiation of NSCLC patients and healthy controls by a urinary microRNA panel
A. Wilke - Raamsteeboers (Enschede, Netherlands), C. Groothuis-Oudshoorn (Enschede, Netherlands), A. De Moor (Enschede, Netherlands), J. Van Der Palen (Enschede, Netherlands), J. De Rooij (Enschede, Netherlands), E. Citgez (Enschede, Netherlands)
| |
LSC - 2020 - Transcriptome signatures of tobacco carcinogens hint the alteration of TAF6 as a specific feature in smokers lung cancer
M. Pepe (München, Germany), A. Lamort (München, Germany), G. Stathopoulos (München, Germany)
| |